The 8-K exhibits an Agreement and Plan of Merger dated July 29, 2026 among MarketAxess Holdings Inc., Intercontinental Exchange, Inc. and Igloo Merger Sub II, Inc. It also includes amendments to employment or severance arrangements for Christopher Concannon, Ilene Fiszel Bieler and Scott Pintoff, while merger schedules were omitted under Regulation S-K.

The risk is buried in the deal mechanics and omitted schedules rather than the headline press release: closing conditions, employment protections, and integration terms will drive spread behavior. Watch for shareholder, regulatory, and merger-arbitrage pushback around the ICE/MKTX tie-up.

Expand disclosed a merger agreement to acquire Twin Eagle N.A., LLC, described as an independent asset-backed natural gas marketing and optimization business. The aggregate consideration is a $1.25 billion base purchase price, subject to working-capital, cash, debt and expense adjustments, and Expand paid a $62.5 million cash deposit at signing.

The risk sits in purchase-price adjustments and closing conditions, including HSR waiting-period expiration and required Canadian approvals. For an energy name, a large marketing-and-optimization acquisition changes risk from commodity exposure toward counterparty, integration, and regulatory execution.

Extreme entered into a five-year $500 million revolving loan facility with JPMorgan Chase Bank, N.A. as administrative agent, replacing its prior credit agreement. As of closing, $200 million was outstanding and $300 million remained available; the facility also includes an uncommitted accordion feature tied partly to the greater of $175 million or 100% of Consolidated EBITDA.

This is not distress financing, but the immediate draw and expanded accordion capacity are leverage signals investors should track. The buried risk is covenant and capital-allocation flexibility: more debt capacity can support growth, but it can also mask pressure if operating momentum fades.

Frequency Electronics completed an offering of 1,739,131 shares at $57.50 per share, including 1,086,957 company shares and 652,174 shares sold by selling stockholders. Gross proceeds to the company before fees and expenses were approximately $62.5 million, and the underwriters received a 30-day option to buy up to 260,869 additional shares from the company.

The headline capital raise strengthens cash, but the buried risk is dilution plus insider/holder liquidity from the secondary component. The additional underwriter option can extend technical pressure if exercised.

Mangoceuticals entered into a business combination agreement with Nuclea Energy Inc. using a Canadian exchangeable-share structure. Before the PIPE share issuance, former Nuclea shareholders would hold approximately 96% of Mango’s equity on a fully diluted, as-exchanged basis, while existing Mango holders would retain about 4%; rights are capped at 19.99% until stockholder and Nasdaq approvals are obtained.

This is ranked below larger established-company filings because it has micro-cap/reverse-merger characteristics, but the dilution math is too explicit to ignore. The key risk is that legacy holders are effectively reset into a small minority position if approvals unlock the full structure.